| 2024-11-13 | -45.8% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript |
| 2024-11-12 | -36.6% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$0.31 misses by $0.27, revenue of $362.1M beats by $2.21M |
| 2024-11-12 | -36.6% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2024-04-01 | -22.3% | analyst | Seeking Alpha | P3 Health Partners just downgraded at BTIG |
| 2021-12-09 | +19.7% | legal | SEC EDGAR | PIII 8-K: 1.01, 2.01, 3.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.06, 7.01 (SEC Filing) |
| 2024-05-23 | +17.6% | news | Seeking Alpha | P3 Health Partners announces ~$42.2M private placement |
| 2024-05-23 | +17.6% | legal | SEC EDGAR | PIII 8-K: 1.01 and 3.02 (SEC Filing) |
| 2024-06-07 | +17.0% | news | Seeking Alpha | P3 Health Partners: Moving In The Right Direction In 2024 |
| 2024-03-29 | -13.9% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript |
| 2025-11-14 | -13.6% | news | Seeking Alpha | P3 Health Partners outlines $120M–$170M EBITDA expansion opportunity for 2026 through operational gains |
| 2025-11-14 | -13.6% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript |
| 2025-11-14 | -13.6% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2025-11-14 | -13.6% | legal | SEC EDGAR | PIII 8-K: 1.01 and (SEC Filing) |
| 2024-03-28 | -13.0% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$0.22 misses by $0.11, revenue of $346.9M beats by $44.17M |
| 2024-03-28 | -13.0% | legal | SEC EDGAR | PIII 8-K: 1.01, 2.02, 2.03, 8.01 (SEC Filing) |
| 2023-05-10 | +12.9% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2023-03-15 | -12.5% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-02-13 | +12.2% | earnings | Seeking Alpha | P3 Health Partners expects FY 2025 revenue between $1.35 billion and $1.5 billion |
| 2023-01-11 | +12.2% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-11-14 | -11.8% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2025-04-15 | +11.7% | news | Intellectia AI | PIII Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2022-10-19 | +10.9% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2024-05-24 | -10.7% | legal | SEC EDGAR | PIII 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-05-09 | -10.6% | legal | SEC EDGAR | PIII 8-K: 5.02 and (SEC Filing) |
| 2025-09-17 | -10.0% | news | Seeking Alpha | P3 Health Partners Inc. (PIII) Presents at IAccess Alpha Virtual Best Ideas Fall Conference 2025 Transcript |
| 2025-11-13 | -8.6% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$9.67 misses by $3.63, revenue of $345.25M misses by $1.39M |
| 2026-03-27 | +8.1% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript |
| 2025-06-03 | -8.1% | legal | SEC EDGAR | PIII 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2025-03-28 | -8.0% | earnings | Seeking Alpha | P3 Health Partners targets profitability in 2025 with adjusted EBITDA guidance of up to $5M |
| 2025-03-28 | -8.0% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript |
| 2022-04-25 | +8.0% | legal | SEC EDGAR | PIII 8-K: 4.02 and 8.01 (SEC Filing) |
| 2023-03-31 | -7.7% | legal | SEC EDGAR | PIII 8-K: 1.01 and 3.02 (SEC Filing) |
| 2023-03-31 | -7.7% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2022-10-27 | -7.3% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2025-02-18 | -7.1% | legal | SEC EDGAR | PIII 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2023-04-25 | +6.5% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2024-08-29 | +6.5% | executive | Seeking Alpha | P3 Health Partners appoints Leif Pedersen as CFO |
| 2024-08-29 | +6.5% | legal | SEC EDGAR | PIII 8-K: 5.02 (SEC Filing) |
| 2024-05-11 | -6.3% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q1 2024 Earnings Call Transcript |
| 2025-05-23 | -6.0% | news | Intellectia AI | SGA Forecast — Price Prediction for 2026. Should I Buy SGA? - Intellectia AI |
| 2025-05-23 | -6.0% | news | Intellectia AI | ELTK Forecast — Price Prediction for 2026. Should I Buy ELTK? - Intellectia AI |
| 2025-05-23 | -6.0% | news | Intellectia AI | AIRE Forecast — Price Prediction for 2026. Should I Buy AIRE? - Intellectia AI |
| 2025-05-23 | -6.0% | news | Intellectia AI | ACET Forecast — Price Prediction for 2026. Should I Buy ACET? - Intellectia AI |
| 2025-05-23 | -6.0% | news | Intellectia AI | ASYS Forecast — Price Prediction for 2026. Should I Buy ASYS? - Intellectia AI |
| 2022-10-20 | -5.7% | legal | SEC EDGAR | PIII 8-K: 2.02, 5.02 (SEC Filing) |
| 2022-10-20 | -5.7% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2026-04-16 | +5.1% | earnings | Business Wire | P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call |
| 2025-05-16 | -5.1% | news | Seeking Alpha | P3 Health Partners reaffirms $130M EBITDA improvement plan as operational initiatives accelerate in 2025 |
| 2025-05-16 | -5.1% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript |
| 2023-01-25 | -4.8% | legal | SEC EDGAR | PIII 8-K: 5.02 (SEC Filing) |
| 2026-03-25 | -4.8% | earnings | GuruFocus.com | P3 Health Partners Inc (PIII) Q4 2025: Everything You Need To Know Ahead Of Earnings |
| 2026-03-25 | -4.8% | legal | SEC EDGAR | PIII 8-K: 1.01 and (SEC Filing) |
| 2025-08-14 | -4.4% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$6.23 misses by $1.93, revenue of $355.7M misses by $3.73M |
| 2025-08-14 | -4.4% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2024-08-08 | -4.2% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q2 2024 Earnings Call Transcript |
| 2024-08-07 | -4.1% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$0.15 misses by $0.05, revenue of $379.2M misses by $2.9M |
| 2024-08-07 | -4.1% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | -3.9% | legal | SEC EDGAR | PIII 8-K: 1.01 and (SEC Filing) |
| 2024-12-17 | +3.9% | legal | SEC EDGAR | PIII 8-K: 1.01, 1.02, 2.03, 3.02 (SEC Filing) |
| 2025-04-04 | +3.7% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2024-01-10 | -3.5% | earnings | Seeking Alpha | P3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimates |
| 2024-01-10 | -3.5% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-05-15 | -3.4% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$6.28 beats by $1.64, revenue of $373.2M beats by $11.13M |
| 2025-05-15 | -3.4% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2025-05-15 | -3.4% | news | Intellectia AI | ASYS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2025-05-15 | -3.4% | news | Intellectia AI | ARMP Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2022-01-12 | +3.3% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-18 | +3.2% | legal | SEC EDGAR | PIII 8-K: 5.02 and (SEC Filing) |
| 2025-05-24 | -2.6% | news | Intellectia AI | ARMP Forecast — Price Prediction for 2026. Should I Buy ARMP? - Intellectia AI |
| 2022-12-13 | -2.5% | legal | SEC EDGAR | PIII 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2021-05-25 | +2.3% | legal | SEC EDGAR | PIII 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-11-09 | +2.3% | legal | SEC EDGAR | PIII 8-K: 8.01 and (SEC Filing) |
| 2026-03-13 | +2.3% | earnings | Business Wire | P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call |
| 2022-12-01 | -2.0% | legal | SEC EDGAR | PIII 8-K: 5.02 and (SEC Filing) |
| 2026-03-26 | -2.0% | news | Business Wire | P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results |
| 2026-03-26 | -2.0% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$23.02 misses by $13.56, revenue of $384.8M beats by $27.15M |
| 2026-03-26 | -2.0% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2024-05-08 | +1.9% | earnings | Seeking Alpha | P3 Health Partners reports Q1 results |
| 2024-05-08 | +1.9% | executive | Seeking Alpha | P3 Health Partners appoints Aric Coffman as chief executive officer |
| 2024-05-08 | +1.9% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2023-04-07 | +1.9% | legal | SEC EDGAR | PIII 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-03-09 | -1.6% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-08 | -1.4% | legal | SEC EDGAR | PIII 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-07-09 | +1.2% | legal | SEC EDGAR | PIII 8-K: 5.02 (SEC Filing) |
| 2023-11-14 | -1.0% | legal | SEC EDGAR | PIII 8-K: 1.01 (SEC Filing) |
| 2021-12-23 | -1.0% | legal | SEC EDGAR | PIII 8-K: 8.01 (SEC Filing) |
| 2025-08-29 | +0.8% | legal | SEC EDGAR | PIII 8-K: 1.01 and (SEC Filing) |
| 2021-11-22 | +0.7% | legal | SEC EDGAR | PIII 8-K: 1.01, 5.07, 8.01 (SEC Filing) |
| 2022-04-14 | +0.7% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2025-03-27 | -0.5% | earnings | Seeking Alpha | P3 Health Partners GAAP EPS of -$0.36 misses by $0.25, revenue of $30.7M misses by $348.18M |
| 2025-03-27 | -0.5% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2023-08-07 | +0.5% | legal | SEC EDGAR | PIII 8-K: 2.02 and (SEC Filing) |
| 2025-04-05 | -0.4% | news | Intellectia AI | PRTS Forecast — Price Prediction for 2026. Should I Buy PRTS? - Intellectia AI |
| 2025-08-15 | +0.4% | expansion | Seeking Alpha | P3 Health Partners outlines $120M–$170M EBITDA improvement opportunity for 2026 while strengthening payer contracts |
| 2025-08-15 | +0.4% | earnings | Seeking Alpha | P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript |
| 2021-06-01 | +0.2% | legal | SEC EDGAR | PIII 8-K: 1.01, 3.02 (SEC Filing) |